Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CANNABIDIOL FOR AUGMENTING VACCINE MEDIATED IMMUNITY AND PROPHYLAXIS OF COVID-19
Document Type and Number:
WIPO Patent Application WO/2022/123550
Kind Code:
A8
Abstract:
The present invention relates to a pharmaceutical composition comprising therapeutically effective amount of Cannabidiol for administration with a Covid-19 vaccine to a mammal / human to sustain and / or enhance effect of vaccine. Further the invention relates to methods to sustain and / or enhance effect of a Covid-19 vaccine in a mammal / human by administering to such a mammal / human a pharmaceutical composition comprising a therapeutically effective amount of Cannabidiol with a Covid-19 vaccine. Administration of Cannabidiol with vaccine can be of following types: i) before administering Covid-19 vaccine; or ii) along with Covid-19 vaccine; or iii) after administering Covid-19 vaccine; or iv) any combination of i, ii and iii including before, along with and after administering Covid-19 vaccine.

Inventors:
MERCHANT SHREEMA (CA)
Application Number:
PCT/IB2022/051304
Publication Date:
August 04, 2022
Filing Date:
February 14, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AKSEERA PHARMA CORP (CA)
MERCHANT SHREEMA (CA)
PATEL MANIT (CA)
International Classes:
A61K31/05; A61K31/352; A61K47/44; A61K47/46; A61P31/12; A61P31/14; C07K14/555; C12Q1/70
Attorney, Agent or Firm:
KHARKAR, Pallavi et al. (IN)
Download PDF: